INKT - MiNK Therapeutics Inc. (INKT) Q1 2024 Earnings Call Transcript
2024-05-14 11:07:01 ET
MiNK Therapeutics, Inc. (INKT)
Q1 2024 Earnings Conference Call
May 14, 2024, 08:30 AM ET
Company Participants
Zack Armen - Head, Investor Relations
Jennifer Buell - President and Chief Executive Officer
Marc Van Dijk - Chief Scientific Officer
Christine Klaskin - Principal Financial and Accounting Officer
Dr. Dhan Chand - Head of Discovery at Agenus
Conference Call Participants
Emily Bodnar - H.C. Wainwright
Jack Allen – Baird
Matthew Phipps - William Blair
Presentation
Operator
Good morning, and welcome to the MiNK Therapeutics' First Quarter 2024 Conference Call and Webcast. [Operator Instructions]. Please note this event is being recorded. If anyone has any objections you may disconnect at this time.
I would now like to turn the conference over to Zack Armen, MiNK’s Investor Relations. Zack go ahead.
Zack Armen
Thank you, Operator, and thank you all for joining us today. Today's call is being webcast and will be available on our website for replay....
MiNK Therapeutics, Inc. (INKT) Q1 2024 Earnings Call Transcript